By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Second generation cephalosporins > Cefotetan > Cefotetan Dosage
Second generation cephalosporins
https://themeditary.com/dosage-information/cefotetan-dosage-10049.html

Cefotetan Dosage

Drug Detail:Cefotetan (Cefotetan [ sef-oh-tee-tan ])

Drug Class: Second generation cephalosporins

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Cesarean Section

1 to 2 g IV one time, as soon as the umbilical cord is clamped

Prophylaxis for cesarean sections is considered controversial in low-risk patients and is not routinely recommended by the American College of Obstetricians and Gynecologists.

Usual Adult Dose for Cholecystitis

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: 7 to 14 days

Usual Adult Dose for Intraabdominal Infection

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: 7 to 14 days

Usual Adult Dose for Joint Infection

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: Therapy should be continued for approximately 3 to 4 weeks, depending on the nature and severity of the infection. Longer therapy, 6 weeks or more, may be required for prosthetic joint infections. In addition, removal of the involved prosthesis is usually required.

Usual Adult Dose for Osteomyelitis

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: Therapy should be continued for approximately 4 to 6 weeks, depending on the nature and severity of the infection. Chronic osteomyelitis may require additional oral antibiotic therapy, possibly for up to 6 months. Surgical debridement of devitalized bone is critical to the management of osteomyelitis.

Usual Adult Dose for Pelvic Inflammatory Disease

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: Parental therapy should be continued for at least 24 hours after clinical improvement is demonstrated. Oral therapy with either doxycycline and clindamycin or metronidazole may then be substituted to complete a 14 day treatment course.

Usual Adult Dose for Peritonitis

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: 10 to 14 days

Usual Adult Dose for Pneumonia

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: Therapy should be continued for approximately 7 days for pneumococcal pneumonia and 21 days for other infecting organisms. The duration of therapy depends on the nature and severity of the infection.

Usual Adult Dose for Pyelonephritis

Moderate: 1 to 2 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Life-threatening: 3 g IV every 12 hours
Duration: 14 days

Usual Adult Dose for Skin or Soft Tissue Infection

Moderate: 2 g IV or IM every 24 hours or 1 g IV or IM every 12 hours
Severe: 2 g IV every 12 hours
Duration: Therapy should be continued for approximately seven days or until three days after acute inflammation disappears. For more severe infections, such as diabetic soft tissue infections, 14 to 21 days of therapy may be required.

Usual Adult Dose for Surgical Prophylaxis

1 to 2 g IV one time, 30 to 60 minutes prior to surgery

Agents with both aerobic and anaerobic activity are indicated in potentially contaminated procedures. Cefotetan is recommended for appendectomies, for colorectal surgeries in patients who are unable to take oral neomycin/erythromycin, and for hysterectomies.

Cefazolin is considered the drug of choice in clean operations because it is active against Staphylococcus aureus and S epidermidis, has a long duration of action, and is relatively inexpensive. Alternatively, vancomycin may be indicated in patients with severe beta-lactam hypersensitivity or for major surgeries at institutions with high rates of MRSA or MRSE infections.

Usual Adult Dose for Urinary Tract Infection

Mild: 500 mg IV or IM every 12 hours
Moderate: 1 to 2 g IV or IM every 24 hours
Severe: 1 to 2 g IV or IM every 12 hours
Duration: 3 to 7 days

Usual Pediatric Dose for Bacterial Infection

1 year or older: 20 to 40 mg/kg IV or IM every 12 hours

Usual Pediatric Dose for Surgical Prophylaxis

1 year or older: 40 mg/kg IV one time, 30 to 60 minutes prior to surgery
For cases of ruptured viscus, gentamicin 2 mg/kg may be added.

Renal Dose Adjustments

CrCl 31 mL/min or more: The usual recommended dose administered every 12 hours.
CrCl 10 to 30 mL/min: The usual dose administered every 24 hours or half the usual dose administered every 12 hours.
CrCl 9 mL/min or less: The usual dose administered every 48 hours or one-fourth of the usual dose administered every 12 hours.

Liver Dose Adjustments

No adjustment recommended

Precautions

Cefotetan is contraindicated in patients who have a history of hemolytic anemia associated with cephalosporin use.

Cefotetan should be discontinued until etiology is determined if anemia develops within 2 or 3 weeks of initiation of therapy.

Patients should be advised to avoid alcohol for at least 3 days after cefotetan use in order to avoid possible disulfiram-like reaction.

Cefotetan solutions should not be physically mixed with aminoglycosides.

Safety and effectiveness have not been established in pediatric patients.

Dialysis

Hemodialysis: One-fourth of the usual dose every 24 hours on days between dialysis and one-half the usual dose on the day of dialysis.

Other Comments

Maximum dosage should not exceed 6 g per 24 hours.

If Chlamydia trachomatis is a suspected pathogen, appropriate antichlamydial coverage should be added, because cefotetan has no activity against this organism.

Cefotetan may be administered intramuscularly; however, IM administration may be painful. The IV route is preferred for severe or life-threatening infections such as sepsis/septicemia, bacteremia, meningitis, peritonitis, and for patients with reduced resistance (i.e., malnutrition, trauma, surgery, heart failure, malignancy, or shock).

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by